This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 51/6/1570    most recent HYPERTENSIONAHA.107.102566v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mito, S. Articles by Yoshizumi, M. Search for Related Content PubMed PubMed Citation Articles by Mito, S. Articles by Yoshizumi, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB IRON Related Collections Animal models of human disease Hypertrophy Oxidant stress

(Hypertension. 2008;51:1570.)
© 2008 American Heart Association, Inc.

Original Articles

Myocardial Protection Against Pressure Overload in Mice Lacking Bach1, a Transcriptional Repressor of Heme Oxygenase-1

Shinji Mito; Ryoji Ozono; Tetsuya Oshima; Yoko Yano; Yuichiro Watari; Yoshiyuki Yamamoto; Andrei Brydun; Kazuhiko Igarashi; Masao Yoshizumi

From the Departments of Cardiovascular Physiology and Medicine (S.M., M.Y.), Clinical Laboratory Medicine (R.O., T.O., Y. Yano), and Medicine and Molecular Science (Y.W., Y. Yamamoto, A.B.), Hiroshima University Graduate School of Biomedical Sciences, Hiroshima; and the Department of Biochemistry (K.I.), Tohoku University Graduate School of Medicine, Tohoku, Japan.

Correspondence to Ryoji Ozono, MD, PhD, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail ozono{at}hiroshima-u.ac.jp

Bach1 is a stress-responsive transcriptional factor that is thought to control the expression levels of cytoprotective factors, including heme-oxygenase (HO)-1. In the present study, we investigated the roles of Bach1 in the development of left ventricular (LV) hypertrophy and remodeling induced by transverse aortic constriction (TAC) in vivo using Bach1 gene-deficient (Bach1^–/–) mice. TAC for 3 weeks in wild-type control (Bach1^+/+) mice produced LV hypertrophy and remodeling manifested by increased heart weight, histological findings showing increased myocyte cross-sectional area (CSA) and interstitial fibrosis (picro Sirius red staining), reexpressions of ANP, BNP, and βMHC genes, and echocardiographic findings showing wall thickening, LV dilatation, and reduced LV contraction. Deletion of Bach1 caused significant reductions in heart weight (by 16%), CSA (by 36%), tissue collagen content (by 38%), and gene expression levels of ANP (by 75%), BNP (by 45%), and βMHC (by 74%). Echocardiography revealed reduced LV dimension and ameliorated LV contractile function. Deletion of Bach1 in the LV caused marked upregulation of HO-1 protein accompanied by elevated HO activity in both basal or TAC-stimulated conditions. Treatment of Bach1^–/– mice with tin-protoporphyrin, an inhibitor of HO, abolished the antihypertrophic and antiremodeling effects of Bach1 gene ablation. These results suggest that deletion of Bach1 caused upregulation of cytoprotective HO-1, thereby inhibiting TAC-induced LV hypertrophy and remodeling, at least in part, through activation of HO. Bach1 repressively controls myocardial HO-1 expression both in basal and stressed conditions, inhibition of Bach1 may be a novel therapeutic strategy to protect the myocardium from pressure overload.

Key Words: hypertrophy • HO-1 • mice • oxidative stress • Bach1 • remodeling